Staff Publications: November 2017

  1. Abbas AM, Strong AT, Diehl DL, et al. Multicenter Evaluation of the Clinical Utility of Laparoscopy-Assisted ERCP in Patients with Roux-En-Y Gastric Bypass. Gastrointest Endosc. 2018;87(4):1031-1039. PMID: 29129525.
  2. Adamsky MA, Boysen WR, Dmochowski RR, Bales GT, Cohn JA. Author Reply. Urology. 2018;111:98. PMID: 29122319.
  3. Ashing KT, Carrington A, Ragin C, Roach V. Examining Hpv- and Hpv Vaccine-Related Cognitions and Acceptability among US-Born and Immigrant Hispanics and US-Born and Immigrant Non-Hispanic Blacks: A Preliminary Catchment Area Study. Cancer Causes Control. 2017;28(11):1341-1347. PMID: 29098504.
  4. Calvo E, Azaro A, Rodon J, et al. Hepatic Safety Analysis of Trabectedin: Results of a Pharmacokinetic Study with Trabectedin in Patients with Hepatic Impairment and Experience from a Phase 3 Clinical Trial. Invest New Drugs. 2018;36(3):476-486. PMID: 29177975.
  5. Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017;171(4):950-965 e928. PMID: 29100075. PMC5693358.
  6. Castaneda CA, Wolfson NA, Leng KR, Kuo YM, Andrews AJ, Fierke CA. HDAC8 Substrate Selectivity Is Determined by Long- and Short-Range Interactions Leading to Enhanced Reactivity for Full-Length Histone Substrates Compared with Peptides. J Biol Chem. 2017;292(52):21568-21577. PMID: 29109148. PMC5766737.
  7. Chang WL, Jackson C, Riel S, et al. Differential Preventive Activity of Sulindac and Atorvastatin in Apc+/Min-Fccc Mice with or without Colorectal Adenomas. Gut. 2018;67(7):1290-1298. PMID: 29122850. PMC6031273.
  8. Cho JH, Patel B, Bonala S, et al. Notch Transactivates Rheb to Maintain the Multipotency of TSC-Null Cells. Nat Commun. 2017;8(1):1848. PMID: 29184052. PMC5705704.
  9. Cuttler JM, Mortazavi SMJ, Welsh JS, Doss M. Re: “Low-Dose Childhood Radiation Effects to the Thyroid Follow a Linear Dose-Response Trend and Persist Even 45+ Years after Exposure” (Clin Thyroidol 2017;29:235-236). Thyroid. 2018;28(5):679-680. PMID: 29132249.
  10. Dasgupta Y, Golovine K, Nieborowska-Skorska M, et al. Drugging DNA Repair to Target T-All Cells. Leuk Lymphoma. 2018;59(7):1746-1749. PMID: 29115896. PMC5940588.
  11. Demark-Wahnefried W, Schmitz KH, Alfano CM, et al. Weight Management and Physical Activity Throughout the Cancer Care Continuum. CA Cancer J Clin. 2018;68(1):64-89. PMID: 29165798. PMC5766382.
  12. Di Marcantonio D, Martinez E, Sidoli S, et al. Protein Kinase C Epsilon Is a Key Regulator of Mitochondrial Redox Homeostasis in Acute Myeloid Leukemia. Clin Cancer Res. 2018;24(3):608-618. PMID: 29127121. PMC5796864.
  13. Dong Y, Zaorsky NG, Li T, et al. Effects of Interruptions of External Beam Radiation Therapy on Outcomes in Patients with Prostate Cancer. J Med Imaging Radiat Oncol. 2018;62(1):116-121. PMID: 29030906. PMC5800942.
  14. Epperla N, Maddocks KJ, Salhab M, et al. C-Myc-Positive Relapsed and Refractory, Diffuse Large B-Cell Lymphoma: Impact of Additional “Hits” and Outcomes with Subsequent Therapy. Cancer. 2017;123(22):4411-4418. PMID: 28749548.
  15. Heckman CJ. Public Parks and Shady Areas in Times of Climate Change, Urban Sprawl, and Obesity. Am J Public Health. 2017;107(12):1856-1858. PMID: 29116832. PMC5678410.
  16. Huang J, Liu Y, Vitale S, et al. On Meta- and Mega-Analyses for Gene-Environment Interactions. Genet Epidemiol. 2017;41(8):876-886. PMID: 29110346. PMC5775907.
  17. Isoda T, Moore AJ, He Z, et al. Non-Coding Transcription Instructs Chromatin Folding and Compartmentalization to Dictate Enhancer-Promoter Communication and T Cell Fate. Cell. 2017;171(1):103-119 e118. PMID: 28938112. PMC5621651.
  18. Jung S, Allen N, Arslan AA, et al. Anti-Mullerian Hormone and Risk of Ovarian Cancer in Nine Cohorts. Int J Cancer. 2018;142(2):262-270. PMID: 28921520. PMC5749630.
  19. Kasireddy V, von Mehren M. Emerging Drugs for the Treatment of Gastrointestinal Stromal Tumour. Expert Opin Emerg Drugs. 2017;22(4):317-329. PMID: 29183145.
  20. Kasivisvanathan V, Kutikov A, Manning TG, et al. Safeguarding the Future of Urological Research and Delivery of Clinical Excellence by Harnessing the Power of Youth to Spearhead Urological Research. Eur Urol. 2018;73(5):645-647. PMID: 29128207.
  21. Kato N, Kawasoe Y, Williams H, et al. Sensing and Processing of DNA Interstrand Crosslinks by the Mismatch Repair Pathway. Cell Rep. 2017;21(5):1375-1385. PMID: 29091773. PMC5806701.
  22. Kit OI, Vodolazhsky DI, Kutilin DS, et al. A Proteomics Analysis Reveals 9 Up-Regulated Proteins Associated with Altered Cell Signaling in Colon Cancer Patients. Protein J. 2017;36(6):513-522. PMID: 29128960.
  23. Klaassen Z, Arora K, Goldberg H, et al. Extended Venous Thromboembolism Prophylaxis after Radical Cystectomy: A Call for Adherence to Current Guidelines. J Urol. 2018;199(4):906-914. PMID: 29113840.
  24. Kluetz PG, Kanapuru B, Lemery S, et al. Informing the Tolerability of Cancer Treatments Using Patient-Reported Outcome Measures: Summary of an FDA and Critical Path Institute Workshop. Value in Health. 2017.
  25. Komiya Y, Bai Z, Cai N, et al. A Nonredundant Role for the TRPM6 Channel in Neural Tube Closure. Sci Rep. 2017;7(1):15623. PMID: 29142255. PMC5688082.
  26. Lheureux S, Butler MO, Clarke B, et al. Association of Ipilimumab with Safety and Antitumor Activity in Women with Metastatic or Recurrent Human Papillomavirus-Related Cervical Carcinoma. JAMA Oncol. 2018;4(7):e173776. PMID: 29145543. PMC6145732.
  27. Manne SL, Myers-Virtue S, Kissane D, et al. Group-Based Trajectory Modeling of Fear of Disease Recurrence among Women Recently Diagnosed with Gynecological Cancers. Psychooncology. 2017;26(11):1799-1809. PMID: 27421919. PMC5507742.
  28. Marty R, Kaabinejadian S, Rossell D, et al. MHC-I Genotype Restricts the Oncogenic Mutational Landscape. Cell. 2017;171(6):1272-1283 e1215. PMID: 29107334. PMC5711564.
  29. Meeker CR, Wong YN, Egleston BL, et al. Distress and Financial Distress in Adults with Cancer: An Age-Based Analysis. J Natl Compr Canc Netw. 2017;15(10):1224-1233. PMID: 28982748.
  30. Messina NM, Rossi K, Wetherhold LM, et al. Optimizing Donor Site Closure Following Bilateral Breast Reconstruction with Abdominal-Based Free Flaps. J Plast Reconstr Aesthet Surg. 2018;71(2):269-271. PMID: 29129588.
  31. Milano RV, Viale E, Bartel MJ, Notaristefano C, Testoni PA. Resection Outcomes and Recurrence Rates of Endoscopic Submucosal Dissection (ESD) and Hybrid ESD for Colorectal Tumors in a Single Italian Center. Surg Endosc. 2018;32(5):2328-2339. PMID: 29098434.
  32. Mo X, Zhang H, Preston S, et al. Interferon-Gamma Signaling in Melanocytes and Melanoma Cells Regulates Expression of CTLA-4. Cancer Res. 2018;78(2):436-450. PMID: 29150430. PMC5771950.
  33. Moore KN, Martin LP, O’Malley DM, et al. A Review of Mirvetuximab Soravtansine in the Treatment of Platinum-Resistant Ovarian Cancer. Future Oncol. 2018;14(2):123-136. PMID: 29098867.
  34. Mortazavi SMJ. Comment on “Technology as a Tool to Encourage Young Adults to Sleep and Eat Healthy”. ACSMS Health & Fitness Journal. 2017;21(6):48-48.
  35. Mortazavi SMJ. Comments on “Incidence of Cancer among Licensed Commercial Pilots Flying North Atlantic Routes”. Environ Health. 2017;16(1):125. PMID: 29149894. PMC5693704.
  36. Myers RM, Hill BT, Shaw BE, et al. Long-Term Outcomes among 2-Year Survivors of Autologous Hematopoietic Cell Transplantation for Hodgkin and Diffuse Large B-Cell Lymphoma. Cancer. 2018;124(4):816-825. PMID: 29125192. PMC5871233.
  37. Nabors LB, Portnow J, Ammirati M, et al. NCCN Guidelines Insights: Central Nervous System Cancers, Version 1.2017. J Natl Compr Canc Netw. 2017;15(11):1331-1345. PMID: 29118226.
  38. Natsuizaka M, Whelan KA, Kagawa S, et al. Interplay between Notch1 and Notch3 Promotes EMT and Tumor Initiation in Squamous Cell Carcinoma. Nat Commun. 2017;8(1):1758. PMID: 29170450. PMC5700926.
  39. Necchi A, Pond GR, Pal SK, et al. Bone Metastases as the Only Metastatic Site in Patients with Urothelial Carcinoma: Focus on a Special Patient Population. Clin Genitourin Cancer. 2018;16(2):e483-e490. PMID: 29158079.
  40. Patt YZ, Murad W, Fekrazad MH, et al. INST OX-05-024: First Line Gemcitabine, Oxaliplatin, and Erlotinib for Primary Hepatocellular Carcinoma and Bile Duct Cancers: A Multicenter Phase II Trial. Cancer Med. 2017;6(9):2042-2051. PMID: 28801995. PMC5603839.
  41. Peri S, Izumchenko E, Schubert AD, et al. NSD1- and NSD2-Damaging Mutations Define a Subset of Laryngeal Tumors with Favorable Prognosis. Nat Commun. 2017;8(1):1772. PMID: 29176703. PMC5701248.
  42. Prabhu VV, Talekar MK, Lulla AR, et al. Single Agent and Synergistic Combinatorial Efficacy of First-in-Class Small Molecule Imipridone ONC201 in Hematological Malignancies. Cell Cycle. 2018;17(4):468-478. PMID: 29157092. PMC5927637.
  43. Reese JB, Bober SL, Daly MB. Talking About Women’s Sexual Health after Cancer: Why Is It So Hard to Move the Needle? Cancer. 2017;123(24):4757-4763. PMID: 29116655. PMC5716835.
  44. Ribas A, Dummer R, Puzanov I, et al. Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy. Cell. 2017;170(6):1109-1119 e1110. PMID: 28886381.
  45. Sartor O, Vogelzang NJ, Sweeney C, et al. Radium-223 Safety, Efficacy, and Concurrent Use with Abiraterone or Enzalutamide: First U.S. Experience from an Expanded Access Program. Oncologist. 2018;23(2):193-202. PMID: 29183960. PMC5813754.
  46. Shaikh T, Handorf EA, Meyer JE, Hall MJ, Esnaola NF. Mismatch Repair Deficiency Testing in Patients with Colorectal Cancer and Nonadherence to Testing Guidelines in Young Adults. JAMA Oncol. 2018;4(2):e173580. PMID: 29121143. PMC5838708.
  47. Somech R, Lev A, Lee YN, et al. Disruption of Thrombocyte and T Lymphocyte Development by a Mutation in ARPC1B. J Immunol. 2017;199(12):4036-4045. PMID: 29127144. PMC5726601.
  48. Sparano JA, Gray R, Oktay MH, et al. A Metastasis Biomarker (Metasite Breast Score) Is Associated with Distant Recurrence in Hormone Receptor-Positive, HER2-Negative Early-Stage Breast Cancer. NPJ Breast Cancer. 2017;3:42. PMID: 29138761. PMC5678158.
  49. Stabler CT, Caires LC, Jr., Mondrinos MJ, et al. Enhanced Re-Endothelialization of Decellularized Rat Lungs. Tissue Eng Part C Methods. 2016;22(5):439-450. PMID: 26935764. PMC4870653.
  50. Tahrir FG, Shanmughapriya S, Ahooyi TM, et al. Dysregulation of Mitochondrial Bioenergetics and Quality Control by HIV-1 Tat in Cardiomyocytes. J Cell Physiol. 2018;233(2):748-758. PMID: 28493473. PMC5673531. NIHMS882650.
  51. Tan CRC, Barta SK, Lee J, Rudek MA, Sparano JA, Noy A. Combination Antiretroviral Therapy Accelerates Immune Recovery in Patients with HIV-Related Lymphoma Treated with EPOCH: A Comparison within One Prospective Trial AMC034. Leuk Lymphoma. 2018;59(8):1851-1860. PMID: 29160731. PMC5962410.
  52. Tetzlaff ED, Hylton HM, DeMora L, Ruth K, Wong YN. National Study of Burnout and Career Satisfaction among Physician Assistants in Oncology: Implications for Team-Based Care. J Oncol Pract. 2018;14(1):e11-e22. PMID: 29190209.
  53. Tomar D, Dong Z, Shanmughapriya S, et al. MCUR1 Is a Scaffold Factor for the MCU Complex Function and Promotes Mitochondrial Bioenergetics. Cell Rep. 2016;15(8):1673-1685. PMID: 27184846. PMC4880542. NIHMS780541.
  54. Tong C, Simhan J. Editorial Comment. J Urol. 2018;199(2):521. PMID: 29097188.
  55. Vachani A, Wong YN, Israelite J, et al. Validation of Molecular Pathology Codes for the Identification of Mutational Testing in Lung and Colon Cancer. Med Care. 2017;55(12):e131-e136. PMID: 29135776.
  56. Vyfhuis MAL, Bhooshan N, Molitoris J, et al. Clinical Outcomes of Black vs. Non-Black Patients with Locally Advanced Non-Small Cell Lung Cancer. Lung Cancer. 2017;114:44-49. PMID: 29173764.
  57. Wahab A, Kesari K, Chaudhary S, et al. Sequential Occurrence of Small Cell and Non-Small Lung Cancer in a Male Patient: Is It a Transformation? Cancer Biol Ther. 2017;18(12):940-943. PMID: 29157085. PMC5718810.
  58. Weinberg DS, Pickhardt PJ, Bruining DH, et al. Computed Tomography Colonography vs Colonoscopy for Colorectal Cancer Surveillance after Surgery. Gastroenterology. 2018;154(4):927-934 e924. PMID: 29174927. PMC5847443.
  59. Wierda WG, Byrd JC, Abramson JS, et al. Hairy Cell Leukemia, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2017;15(11):1414-1427. PMID: 29118233.
  60. Wong YN, Manola J, Hudes GR, et al. Phase 2 Study of Weekly Paclitaxel Plus Estramustine in Metastatic Hormone-Refractory Prostate Carcinoma: ECOG-ACRIN Cancer Research Group (E1898) Trial. Clin Genitourin Cancer. 2018;16(2):e315-e322. PMID: 29173976. PMC5975965.
  61. Xu B, Chakraborty H, Yadav VK, Zhang Z, Klein ML, Ren S. Author Correction: Tunable Two-Dimensional Interfacial Coupling in Molecular Heterostructures. Nat Commun. 2017;8(1):1699. PMID: 29150607. PMC5693927.
  62. Xu J, Cortellino S, Tricarico R, et al. Thymine DNA Glycosylase (TDG) is Involved in the Pathogenesis of Intestinal Tumors with Reduced APC Expression. Oncotarget. 2017;8(52):89988-89997. PMID: 29163805. PMC5685726.
  63. Zhao S, Tang H, Yan D, et al. DDA1 Promotes Stage IIb-IIc Colon Cancer Progression by Activating NFκB/CSN2/GSK-3β Signaling. Oncotarget. 2016;7(15):19794-19812. PMID: 26942699. PMC4991419.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s